Ramm Pharma Corp (TSE:RAMM) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
RAMM Pharma Corp., a leader in cannabinoid pharmacology, has cancelled its previously announced private placement after withdrawing its appeal against the Canadian Securities Exchange’s decision which required shareholder approval. The company, with international production and sales in pharmaceuticals and hemp-based products, will communicate future financing plans at a later date. This strategic shift comes despite RAMM’s robust product pipeline and established market presence in Latin America and Europe.
For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.